T 1054/06 (Quinoxaline derivatives/AVENTIS PHARMACEUTICALS) of 22.09.2009
- European Case Law Identifier
- ECLI:EP:BA:2009:T105406.20090922
- Date of decision
- 22 September 2009
- Case number
- T 1054/06
- Petition for review of
- -
- Application number
- 98925041.0
- IPC class
- C07D 241/52
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56Ick tyrosine kinases
- Applicant name
- Aventis Pharmaceuticals Inc.
- Opponent name
- -
- Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 111(1)European Patent Convention Art 123(2)European Patent Convention Art 83European Patent Convention Art 84
- Keywords
- Amendments - allowable (yes)
Clarity - (yes)
Sufficiency of disclosure (yes)
Remittal - Catchword
- -
- Citing cases
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance for further prosecution on the basis of the sole and main request currently on file.